Novo Nordisk invests USD 2.6bn in new manufacturing facilities

The pharmaceutical company plans to build three new manufacturing facilities and to expand one factory in the Danish city of Kalundborg. Construction is anticipated to create around 400 new jobs.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
by mikkel aabenhus hemmingsen

With an investment of DKK 17bn (USD 2.6bn), Novo Nordisk seeks to strengthen all of the links in its global value chain, from drug production to packaging, it announces in a press release on Monday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading